Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100722 · ClinicalTrials.gov registry record · NA
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
A NA study of Coronary Disease and Coronary Stenosis, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 20
- Study locations
NCT02100722 is a NA study of Coronary Disease and Coronary Stenosis that has completed, run by Stanford University. The registered enrollment target is 1,500 participants, below the 1,975-participant average among 34 other Coronary Disease trials with a reported enrollment target (24% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT02100722, a NA study of Coronary Disease and Coronary Stenosis, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in similar outcomes to coronary artery bypass graft surgery (CABG).
Conditions Studied
Interventions
- PROCEDURE CABG
- PROCEDURE FFR guided PCI
- DEVICE Resolute Integrity Stent
- DEVICE Resolute Onyx Stent
Study Locations (20)
Other
- Peninsula Health - Frankston
- St. Vincent's Hospital Melbourne - Melbourne
- Concord Hospital - Sydney
- Royal North Shore - Sydney
- University of Sydney - Sydney
- Cardiovascular Center Aalst - Aalst
- Le'Centre Hospitalier de l'Universite de Montreal - Montreal
California
- Palo Alto VA - Palo Alto
- Stanford University - Stanford
Kentucky
- Lexinton VA - Lexington
- University of Kentucky Medical Center - Lexington
Georgia
- Atlanta VA Medical Center - Decatur
Illinois
- Jesse Brown VA Medical Center - Chicago
Kansas
- University of Kansas Medical Center - Lawrence
Massachusetts
- Baystate Medical Center - Springfield
Minnesota
- HealthEast St. Joseph's Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2014-08-25 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02100722
The ClinicalTrials.gov registry entry for NCT02100722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,975-participant average among 34 other Coronary Disease trials with a reported enrollment target (24% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronary Disease appearing as the primary indexed condition, and to 4 interventions - of which CABG is the first listed.
NCT02100722 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Other, California, Kentucky.
Frequently Asked Questions
What is clinical trial NCT02100722 about?
NCT02100722 is a clinical study titled "A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease". The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in sim...
What is the current status of trial NCT02100722?
This trial is currently completed. It is a NA study. The enrollment target is 1,500 participants. The study started on 2014-08-25. Estimated completion is 2024-12-01.
What conditions does trial NCT02100722 study?
This clinical trial studies the following conditions: Coronary Disease, Coronary Stenosis.
What interventions are being tested in trial NCT02100722?
The interventions under investigation include: CABG (PROCEDURE), FFR guided PCI (PROCEDURE), Resolute Integrity Stent (DEVICE), Resolute Onyx Stent (DEVICE).
Who is sponsoring clinical trial NCT02100722?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02100722 being conducted?
This trial has 20 study locations across California, Georgia, Illinois, Kansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating New Radiation Techniques for Cardiovascular Imaging
RECRUITING · NA
-
Sapphire 3 CTO Study
COMPLETED · NA
-
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
COMPLETED · NA
-
Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women
COMPLETED · NA
-
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
COMPLETED · NA
-
Time Restricted Feeding for Weight Loss and Cardio-protection
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.